BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 21971199)

  • 1. [Post-stroke depression: recognition and treatment interventions].
    Arseniou S; Arvaniti A; Samakouri M
    Psychiatriki; 2011; 22(3):240-8. PubMed ID: 21971199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Post-stroke depression (II): its differential diagnosis, complications and treatment].
    Carod-Artal FJ
    Rev Neurol; 2006 Feb 16-28; 42(4):238-44. PubMed ID: 16521063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is it safe to use antidepressants after a stroke?
    Rampello L; Battaglia G; Raffaele R; Vecchio I; Alvano A
    Expert Opin Drug Saf; 2005 Sep; 4(5):885-97. PubMed ID: 16111451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Depression after stroke: a review of the evidence base to inform the development of an integrated care pathway. Part 2: Treatment alternatives.
    Turner-Stokes L; Hassan N
    Clin Rehabil; 2002 May; 16(3):248-60. PubMed ID: 12017512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Post-stroke depression.
    Lenzi GL; Altieri M; Maestrini I
    Rev Neurol (Paris); 2008 Oct; 164(10):837-40. PubMed ID: 18771785
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advances in antidepressants for treating post-stroke depression.
    Paolucci S
    Expert Opin Pharmacother; 2017 Jul; 18(10):1011-1017. PubMed ID: 28535081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Post-stroke depression.
    Gupta A; Pansari K; Shetty H
    Int J Clin Pract; 2002 Sep; 56(7):531-7. PubMed ID: 12296616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Post-stroke depression: an update.
    Espárrago Llorca G; Castilla-Guerra L; Fernández Moreno MC; Ruiz Doblado S; Jiménez Hernández MD
    Neurologia; 2015; 30(1):23-31. PubMed ID: 22901370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective serotonin reuptake inhibitors and the tricyclic antidepressant nortriptyline in the treatment of post stroke depression.
    Hackett M; Anderson C; House A
    Top Stroke Rehabil; 2004; 11(1):viii; author reply ix. PubMed ID: 15000073
    [No Abstract]   [Full Text] [Related]  

  • 10. Antidepressant therapy in post-stroke depression.
    Starkstein SE; Mizrahi R; Power BD
    Expert Opin Pharmacother; 2008 Jun; 9(8):1291-8. PubMed ID: 18473704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prediction of the response to citalopram and reboxetine in post-stroke depressed patients.
    Rampello L; Chiechio S; Nicoletti G; Alvano A; Vecchio I; Raffaele R; Malaguarnera M
    Psychopharmacology (Berl); 2004 Apr; 173(1-2):73-8. PubMed ID: 14685645
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A naturalistic study of suicidal adolescents treated with an SSRI: suicidal ideation and behavior during 3-month post-hospitalization period.
    Ghaziuddin N; Merchant C; Dopp R; King C
    Asian J Psychiatr; 2014 Oct; 11():13-9. PubMed ID: 25453691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The SNRI venlafaxine improves emotional unawareness in patients with post-stroke depression.
    Cravello L; Caltagirone C; Spalletta G
    Hum Psychopharmacol; 2009 Jun; 24(4):331-6. PubMed ID: 19330795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical significance and possibilities of therapy of post-stroke depression].
    Trusova NA; Levin OS
    Zh Nevrol Psikhiatr Im S S Korsakova; 2019; 119(9. Vyp. 2):60-67. PubMed ID: 31825392
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reducing suicidal ideation and depressive symptoms in depressed older primary care patients: a randomized controlled trial.
    Bruce ML; Ten Have TR; Reynolds CF; Katz II; Schulberg HC; Mulsant BH; Brown GK; McAvay GJ; Pearson JL; Alexopoulos GS
    JAMA; 2004 Mar; 291(9):1081-91. PubMed ID: 14996777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The psychopharmacology of brain vascular disease/poststroke depression.
    Jones M; Corcoran A; Jorge RE
    Handb Clin Neurol; 2019; 165():229-241. PubMed ID: 31727214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Apathy syndrome in depressed patients previously treated with selective serotonin reuptake inhibitors].
    Petrova NN; Markin AV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2020; 120(1):111-117. PubMed ID: 32105278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic effects of milnacipran, a serotonin and noradrenaline reuptake inhibitor, on post-stroke depression.
    Kimura M; Kanetani K; Imai R; Suzuki H; Isayama K; Endo S
    Int Clin Psychopharmacol; 2002 May; 17(3):121-5. PubMed ID: 11981353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological management of post-stroke depression: an update of the evidence and clinical guidance.
    Mortensen JK; Andersen G
    Expert Opin Pharmacother; 2021 Jun; 22(9):1157-1166. PubMed ID: 33530765
    [No Abstract]   [Full Text] [Related]  

  • 20. [Stroke and depression].
    Sivolap YP; Damulin IV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2019; 119(9):143-147. PubMed ID: 31626232
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.